SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ACMI - Accumed Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Frank Buck who wrote (1239)1/22/1998 12:24:00 AM
From: Sigmund  Read Replies (1) of 1894
 
One argument for taking NewCo public would be if it were more desirable from an investment point of view than is ACMI. I am not sure that this would be the case. If it were and if NewCo were public and traded at a better price to asset or other measure (see Fluff analysis) than this would help establish the value of ACMI.

If ACMI owned 30% of NewCo and if NewCo had a market cap of $100MM then ACMI should have a market cap of $30MM plus whatever value is assigned to the rest of ACMI not in NewCo. But unfortunately, I don't think that NewCo will have a $100MM market cap anytime soon. Also I think it is true that companies usually sell at a discount to the breakup value of their subsidiaries. Cable and Wireless is a good example of this. Their market cap usually just about equals the value of their holdings in Hong Kong Telecom with the market valuing the remainder of their assets at essentially zero.

So I think that this is perhaps an unnecessary strategy by ACMI unless they see NewCo going off on its own acquisition program or being very aggessive re R&D.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext